Good News! China’s First Batch! BioAlly Feline Triple Vaccine Has Been Successfully Approved!

2023-11-03

概要： On August 23, 2023, Announcement No. 701 of the Ministry of Agriculture and Rural Affairs was issued, announcing that BioAlly’s independently developed trivalent inactivated vaccine against feline panleukopenia, feline rhinotracheitis, and feline calicivirus (strains HBX05, BJS01, and BJH13) has successfully passed the emergency evaluation conducted by the Ministry and has been approved. This milestone marks the first-ever domestically produced feline vaccine.

On August 23, 2023, Announcement No. 701 of the Ministry of Agriculture and Rural Affairs was issued, announcing that BioAlly’s independently developed trivalent inactivated vaccine against feline panleukopenia, feline rhinotracheitis, and feline calicivirus (strains HBX05, BJS01, and BJH13) had successfully passed the emergency evaluation conducted by the Ministry and received approval. This milestone marks the first-ever domestically produced feline vaccine.

The world has long been plagued by substandard feline vaccines, and Chinese cat owners deserve access to high-quality, domestically produced vaccines. The approval and launch of BioAlly’s “Feline Triple Vaccine” will inject powerful domestic momentum into the pet vaccine market. Guided by our original mission to ensure that Chinese pets receive superior, locally made vaccines, BioAlly will continue to deepen our commitment to the pet biopharmaceutical sector, providing Chinese veterinarians with effective, homegrown biological products that safeguard the health of China’s beloved pets and bring joy and happiness to their devoted “pet parents.”